SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

R1 Therapeutics expands Series A financing to $80.5 million with Samsara Biocapital

Reuters reports R1 Therapeutics expanded its Series A financing to $80.5 million, with investment from Samsara Biocapital.

BRIEF

Related stories